Avanos Medical, Inc. AVNS

Full chart Compare
Set alert

Price alert · AVNS

All alert types
24.99 USD 0.00 (+0.00%)

At closeJul 24, 2026, 4:03 PM EDT

24.95 -0.04 -0.16%

After hours · Jul 24, 4:03 PM ET

24.98 Day range 25.00

52-week range unavailable

YTD
+122.53%
1 year
+105.34%
Market cap
1.17B
Profit margin
-9.69%
YTD return
+122.53%
1-year return
+105.34%
Volume
432.16K
Open
24.98
Previous close
24.99
Day's range
24.98 – 25.00
Earnings date
Aug 10, 2026

 

No chart data for this range yet.

Key statistics

Enterprise value
1.24B
PEG ratio
-0.39
Price / sales
0.00
Price / book
1.48
Dividend yield
0.00%
Payout ratio
0.00%
Total cash
0
Total debt
3
Return on equity
-8.91%
50-day average
0.00
200-day average
0.00

Financials — quick view

All financials
AVNS Revenue — quarterly 182.20M
2022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 2026
AVNS Net income — quarterly 5.10M
2022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 2026
AVNS EPS — quarterly 0.11
2022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 2026

Earnings

AVNS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 10, 2026Jun 30, 20260.16———
May 5, 2026Mar 31, 20260.160.22+0.06+37.50%
Feb 24, 2026Dec 31, 20250.240.29+0.05+20.83%
Nov 5, 2025Sep 30, 20250.120.22+0.10+83.33%
Aug 5, 2025Jun 30, 20250.180.17-0.01-5.56%
May 6, 2025Mar 31, 20250.190.26+0.07+36.84%

Upgrades / downgrades

AVNS analyst upgrades and downgrades
DateFirmActionFromTo
May 7, 2024JMP Securitiesreit—Market Perform
Jul 25, 2023KeybancdownOverweightSector Weight
Jun 21, 2023StifelreitHoldHold
May 22, 2023CL Kinginit—Buy
May 4, 2023Morgan Stanleymain—Underweight
Feb 22, 2023Morgan Stanleymain—Underweight

About Avanos Medical, Inc.

Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solutions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.

Sector
Healthcare
Industry
Medical - Devices
Country
US
Employees
2,287
Website
avanos.com

News

Your note

Sign in to keep a note on AVNS — it syncs with the Stock Master app.